Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Medtronic
Harvard Business School
Mallinckrodt
Baxter
Merck
Dow

Last Updated: March 31, 2020

DrugPatentWatch Database Preview

CLEOCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Which patents cover Cleocin Phosphate In Dextrose 5% In Plastic Container, and when can generic versions of Cleocin Phosphate In Dextrose 5% In Plastic Container launch?

Cleocin Phosphate In Dextrose 5% In Plastic Container is a drug marketed by Pharmacia And Upjohn and is included in one NDA.

The generic ingredient in CLEOCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER is clindamycin phosphate. There are fifty-five drug master file entries for this compound. Thirty-three suppliers are listed for this compound. Additional details are available on the clindamycin phosphate profile page.

US ANDA Litigation and Generic Entry Outlook for Cleocin Phosphate In Dextrose 5% In Plastic Container

A generic version of CLEOCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER was approved as clindamycin phosphate by ALVOGEN INC on July 24th, 1987.

  Start Trial

Summary for CLEOCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER
Drug patent expirations by year for CLEOCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER
Recent Clinical Trials for CLEOCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
GlaxoSmithKlinePhase 1
Stiefel, a GSK CompanyPhase 1

See all CLEOCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER clinical trials

Pharmacology for CLEOCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER

US Patents and Regulatory Information for CLEOCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn CLEOCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER clindamycin phosphate INJECTABLE;INJECTION 050639-001 Aug 30, 1989 AP RX Yes Yes   Start Trial   Start Trial   Start Trial
Pharmacia And Upjohn CLEOCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER clindamycin phosphate INJECTABLE;INJECTION 050639-002 Aug 30, 1989 AP RX Yes Yes   Start Trial   Start Trial   Start Trial
Pharmacia And Upjohn CLEOCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER clindamycin phosphate INJECTABLE;INJECTION 050639-003 Apr 10, 1991 AP RX Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Harvard Business School
Mallinckrodt
Baxter
Merck
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.